Tuesday, April 28, 2020

Glenmark Pharma gets tentative USFDA nod for generic anti-diabetes tablets

Glenmark Pharma gets tentative USFDA nod for generic anti-diabetes tablets The approval granted by the United States Food and Drug Administration (USFDA) to Glenmark Pharmaceuticals Inc., USA, is for the strength of 10 mg/5 mg tablets, the generic version of Qtern tablets of the same strength of AstraZeneca AB, the company said in a statement.

from Moneycontrol Business News https://ift.tt/3d02wA2
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

US stock: S&P 500 ends lower as investors weigh data, Middle East tensions

The S&P 500's streak came to an end, falling from its peak as weaker retail sales suggested caution among consumers. Despite a stron...